NASDAQ:SRPT - Sarepta Therapeutics News Headlines

$142.77
-1.95 (-1.35 %)
(As of 07/23/2019 09:40 AM ET)
Today's Range
$142.70
Now: $142.7671
$145.57
50-Day Range
$115.26
MA: $138.37
$158.10
52-Week Range
$95.21
Now: $142.7671
$165.87
Volume57,928 shs
Average Volume1.50 million shs
Market Capitalization$10.59 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.12

Headlines

Sarepta Therapeutics (NASDAQ SRPT) News Headlines

Source:
DateHeadline
Zacks: Analysts Anticipate Sarepta Therapeutics Inc (NASDAQ:SRPT) Will Post Quarterly Sales of $91.26 MillionZacks: Analysts Anticipate Sarepta Therapeutics Inc (NASDAQ:SRPT) Will Post Quarterly Sales of $91.26 Million
www.americanbankingnews.com - July 23 at 2:46 AM
Sarepta Therapeutics Inc (NASDAQ:SRPT) Expected to Announce Earnings of -$1.08 Per ShareSarepta Therapeutics Inc (NASDAQ:SRPT) Expected to Announce Earnings of -$1.08 Per Share
www.americanbankingnews.com - July 21 at 4:10 PM
Is Sarepta Therapeutics (SRPT) Stock Outpacing Its Medical Peers This Year?Is Sarepta Therapeutics (SRPT) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - July 18 at 7:31 PM
William Blair Analysts Boost Earnings Estimates for Sarepta Therapeutics Inc (NASDAQ:SRPT)William Blair Analysts Boost Earnings Estimates for Sarepta Therapeutics Inc (NASDAQ:SRPT)
www.americanbankingnews.com - July 18 at 8:07 AM
Sarepta vs Pfizer: Which Stock Should Investors Buy?Sarepta vs Pfizer: Which Stock Should Investors Buy?
finance.yahoo.com - July 17 at 8:15 AM
Sarepta Therapeutics Looks Ready to Break Out to the UpsideSarepta Therapeutics Looks Ready to Break Out to the Upside
finance.yahoo.com - July 12 at 7:16 PM
Sarepta Therapeutics Inc (NASDAQ:SRPT) Receives Average Rating of "Buy" from AnalystsSarepta Therapeutics Inc (NASDAQ:SRPT) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 12 at 12:35 PM
Sarepta Soars As Pfizers DMD Prospects LanguishSarepta Soars As Pfizer's DMD Prospects Languish
seekingalpha.com - July 12 at 8:11 AM
Sarepta Gains After Pfizer Suffers A Setback With Gene Therapy For DMDSarepta Gains After Pfizer Suffers A Setback With Gene Therapy For DMD
seekingalpha.com - July 10 at 8:16 AM
Sarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $220.00 at Morgan StanleySarepta Therapeutics (NASDAQ:SRPT) Price Target Raised to $220.00 at Morgan Stanley
www.americanbankingnews.com - July 9 at 10:12 AM
Sarepta Stock Up Almost 40% This Year So Far: Heres WhySarepta Stock Up Almost 40% This Year So Far: Here's Why
finance.yahoo.com - July 8 at 7:03 PM
Sarepta Up as Pfizers DMD Gene Therapy Faces Safety IssuesSarepta Up as Pfizer's DMD Gene Therapy Faces Safety Issues
finance.yahoo.com - July 1 at 7:11 PM
Sarepta Therapeutics Stock Could Capitalize From Pfizer’s StumbleSarepta Therapeutics Stock Could Capitalize From Pfizer’s Stumble
finance.yahoo.com - July 1 at 7:11 PM
Royal Bank of Canada Raises Sarepta Therapeutics (NASDAQ:SRPT) Price Target to $220.00Royal Bank of Canada Raises Sarepta Therapeutics (NASDAQ:SRPT) Price Target to $220.00
www.americanbankingnews.com - July 1 at 10:36 AM
Sarepta Therapeutics Inc (NASDAQ:SRPT) Expected to Post Quarterly Sales of $91.16 MillionSarepta Therapeutics Inc (NASDAQ:SRPT) Expected to Post Quarterly Sales of $91.16 Million
www.americanbankingnews.com - June 30 at 1:24 AM
Zacks: Analysts Expect Sarepta Therapeutics Inc (NASDAQ:SRPT) Will Announce Earnings of -$1.08 Per ShareZacks: Analysts Expect Sarepta Therapeutics Inc (NASDAQ:SRPT) Will Announce Earnings of -$1.08 Per Share
www.americanbankingnews.com - June 28 at 10:15 PM
Pfizer Fails to Best Sarepta With Early Data on DMD Gene TherapyPfizer Fails to Best Sarepta With Early Data on DMD Gene Therapy
www.bloomberg.com - June 28 at 6:49 PM
Sarepta jumps 19% as fears ebb over superiority of Pfizer DMD dataSarepta jumps 19% as fears ebb over superiority of Pfizer DMD data
seekingalpha.com - June 28 at 6:49 PM
Heres Why Sarepta Therapeutics Is Surging TodayHere's Why Sarepta Therapeutics Is Surging Today
finance.yahoo.com - June 28 at 6:49 PM
5 Top Stock Trades for Monday: STZ, C, UBER5 Top Stock Trades for Monday: STZ, C, UBER
investorplace.com - June 28 at 3:39 PM
Noteworthy Thursday Option Activity: SRPT, FDP, ZBRANoteworthy Thursday Option Activity: SRPT, FDP, ZBRA
www.nasdaq.com - June 27 at 7:02 PM
Are Options Traders Betting on a Big Move in Sarepta Therapeutics (SRPT) Stock?Are Options Traders Betting on a Big Move in Sarepta Therapeutics (SRPT) Stock?
finance.yahoo.com - June 27 at 7:02 PM
Sarepta Therapeutics: Judgement Day ComethSarepta Therapeutics: Judgement Day Cometh
seekingalpha.com - June 25 at 12:05 PM
The Sarepta Therapeutics (NASDAQ:SRPT) Share Price Is Up 612% And Shareholders Are DelightedThe Sarepta Therapeutics (NASDAQ:SRPT) Share Price Is Up 612% And Shareholders Are Delighted
finance.yahoo.com - June 18 at 4:41 PM
Here’s What Hedge Funds Think About Sarepta Therapeutics Inc (SRPT)Here’s What Hedge Funds Think About Sarepta Therapeutics Inc (SRPT)
finance.yahoo.com - June 10 at 7:05 PM
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?
finance.yahoo.com - June 9 at 8:08 AM
Sarepta Therapeutics (SRPT) Up 2.9% Since Last Earnings Report: Can It Continue?Sarepta Therapeutics (SRPT) Up 2.9% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - June 7 at 4:06 PM
Sarepta Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare ConferenceSarepta Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
finance.yahoo.com - June 4 at 6:59 PM
Notable Tuesday Option Activity: SRPT, WMT, HLFNotable Tuesday Option Activity: SRPT, WMT, HLF
www.nasdaq.com - May 28 at 6:31 PM
Market Weekly Review: Lower Prices Create Buying OpportunitiesMarket Weekly Review: Lower Prices Create Buying Opportunities
finance.yahoo.com - May 26 at 8:04 AM
Independent research group finds scant evidence of efficacy for Sareptas exon-skipping DMD medsIndependent research group finds scant evidence of efficacy for Sarepta's exon-skipping DMD meds
seekingalpha.com - May 23 at 7:36 PM
SRPT July 5th Options Begin TradingSRPT July 5th Options Begin Trading
www.nasdaq.com - May 23 at 7:36 PM
Sarepta Therapeutics (SRPT) Presents At Annual Meeting of the American Society of Gene and Cell Therapy - SlideshowSarepta Therapeutics (SRPT) Presents At Annual Meeting of the American Society of Gene and Cell Therapy - Slideshow
seekingalpha.com - May 14 at 8:12 PM
SRPT June 28th Options Begin TradingSRPT June 28th Options Begin Trading
www.nasdaq.com - May 13 at 8:10 PM
Sarepta Therapeutics (SRPT) Q1 2019 Earnings Call TranscriptSarepta Therapeutics (SRPT) Q1 2019 Earnings Call Transcript
www.fool.com - May 10 at 1:49 AM
Notable Thursday Option Activity: SRPT, CARG, GDOTNotable Thursday Option Activity: SRPT, CARG, GDOT
www.nasdaq.com - May 9 at 7:59 PM
When Can We Expect A Profit From Sarepta Therapeutics, Inc. (NASDAQ:SRPT)?When Can We Expect A Profit From Sarepta Therapeutics, Inc. (NASDAQ:SRPT)?
finance.yahoo.com - May 9 at 7:59 PM
Edited Transcript of SRPT earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of SRPT earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 7:59 PM
Sarepta Q1 top line up 35% on EXONDYS 51 demandSarepta Q1 top line up 35% on EXONDYS 51 demand
seekingalpha.com - May 8 at 7:48 PM
Sarepta Therapeutics beats by $0.84, beats on revenueSarepta Therapeutics beats by $0.84, beats on revenue
seekingalpha.com - May 8 at 7:48 PM
Sarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue EstimatesSarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 8 at 7:48 PM
Sarepta Therapeutics Q1 2019 Earnings PreviewSarepta Therapeutics Q1 2019 Earnings Preview
seekingalpha.com - May 7 at 7:12 PM
These 6 biotech stocks are promising takeover targetsThese 6 biotech stocks are promising takeover targets
finance.yahoo.com - May 2 at 8:09 AM
Sarepta Therapeutics to Announce First Quarter 2019 Financial Results and Recent Corporate Developments on May 8, 2019Sarepta Therapeutics to Announce First Quarter 2019 Financial Results and Recent Corporate Developments on May 8, 2019
finance.yahoo.com - May 1 at 7:39 PM
Sarepta down 5% on looming data readout on Pfizer DMD candidateSarepta down 5% on looming data readout on Pfizer DMD candidate
seekingalpha.com - April 30 at 7:04 PM
Sarepta CEOs pay dropped 98 percent in 2018Sarepta CEO's pay dropped 98 percent in 2018
www.bizjournals.com - April 29 at 6:54 PM
Whats in the Cards for Sarepta (SRPT) This Earnings Season?What's in the Cards for Sarepta (SRPT) This Earnings Season?
finance.yahoo.com - April 29 at 6:54 PM
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseSarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
finance.yahoo.com - April 25 at 7:27 PM
3 Stocks Warren Buffett Would Love3 Stocks Warren Buffett Would Love
finance.yahoo.com - April 23 at 8:03 AM
Interesting SRPT Put And Call Options For May 31stInteresting SRPT Put And Call Options For May 31st
www.nasdaq.com - April 15 at 7:38 PM
This page was last updated on 7/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel